Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails.
Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment often lasts for an average period of six months. In recent past, advancement in therapy with the introduction of effective topical and oral products has controlled the rapid spread of dermatophytic onychomycosis.

Market Analysis and Insights: Global Dermatophytic Onychomycosis Treatment Market
The global Dermatophytic Onychomycosis Treatment market size is projected to reach US$ 2014.6 million by 2027, from US$ 1201.2 million in 2020, at a CAGR of 7.2% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermatophytic Onychomycosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermatophytic Onychomycosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermatophytic Onychomycosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermatophytic Onychomycosis Treatment market.

Global Dermatophytic Onychomycosis Treatment Scope and Market Size
Dermatophytic Onychomycosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermatophytic Onychomycosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Systemic Therapy
Topical Therapy
Others

Segment by Application
Hospitals
Dermatology Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bausch Health Companies
Novartis AG
Johnson and Johnson
Galderma S.A.
Celtic Pharmaceuticals
Anacor Pharmaceuticals
Moberg Pharma AB
GlaxoSmithKline
Pfizer Inc